Nivolumab vs Oxycodone
Nivolumab vs Oxycodone: Overview
This comparison examines the pharmacological differences between Nivolumab and Oxycodone.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Oxycodone: Semisynthetic mu-opioid receptor agonist.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Oxycodone β 3-5 hours.
Chemical Properties
Molecular Formula: Oxycodone β C18H21NO4.
Molecular Weight: Oxycodone β 315.3640 g/mol.
Type: Nivolumab β Antibody; Oxycodone β Small molecule.